The Glaxo International Postmarketing Surveillance System: Present and Future

Abstract

The Glaxo worldwide system for monitoring the safety profile of its marketed and investigational products is described. This paper specifically focuses on the coordinated development of drug surveillance activities between Glaxo Group Research (United Kingdom) and Glaxo Inc. (United States). Central to this dedicated effort is a single worldwide computer system for the storage, monitoring and retrieval of adverse event data.

Keywords

Computer systems Coding dictionaries Drug surveillance Algorithms Data processing

Get full access to this article

View all access options for this article.

References

Dobbs

. Exchange of worldwide safety surveillance data via an international computer database. Drug Inf J. 1988;22: 71–74.

Talbot

JCC

. Database management and reporting systems — Foreign-based companies: The Glaxo approach. Drug Inf J. 1989;23: 189–196.